Gsk Aktie - GSK

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

1.354,00

Gebot

1.353,00

Fragen

1.353,50

Volumen

3.752.810

1.352,00 Tagesbereich 1.364,50

1.282,50 52-Wochen-Bereich 1.820,00

Marktkapitalisierung

56,125B

Handelsende

1.359,00

Handelsbeginn

1.356,50

Letzte Trade

2729

1354

(O)

Letzter Handelszeitpunkt

Finanzvolumen

50.925.403p

VWAP

1.356,9939

Durchschnittliches Volumen (3 Mio.)

8.051.701

Ausgegebene Aktien

4.145.132.579

Dividendenrendite

4.43%

Kurs-Gewinn-Verhältnis

11,38

Gewinn pro Aktie (EPS)

1,19

Erlöse

30,33B

Nettogewinn

4,93B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.gsk.com

Hauptsitz

London, Gbr

Gegründet

Gsk Plc is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker GSK. The last closing price for Gsk was 1.359,00p. Over the last year, Gsk shares have traded in a share price range of 1.282,50p to 1.820,00p.

Gsk currently has 4.145.132.579 shares in issue. The market capitalisation of Gsk is £56,33 billion. Gsk has a price to earnings ratio (PE ratio) of 11.38.

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemo ...

GSK PLC Jemperli expanded approval in the EU

GSK PLC 20 January 2025 Issued: 20 January 2025, London UK European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or...

GSK PLC Director/PDMR Shareholding

GSK PLC 16 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name David Redfern b) Position/status President...

GSK PLC Director/PDMR Shareholding

GSK PLC 15 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 14 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 13 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its " ...

GSK PLC GSK enters agreement to acquire IDRx, Inc.

GSK PLC 13 January 2025 Issued: 13 January 2025, London UK GSK enters agreement to acquire IDRx, Inc. · Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor...

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemo ...

GSK PLC Jemperli expanded approval in the EU

GSK PLC 20 January 2025 Issued: 20 January 2025, London UK European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or...

GSK PLC Director/PDMR Shareholding

GSK PLC 16 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name David Redfern b) Position/status President...

GSK PLC Director/PDMR Shareholding

GSK PLC 15 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 14 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC Director/PDMR Shareholding

GSK PLC 13 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its " ...

GSK PLC GSK enters agreement to acquire IDRx, Inc.

GSK PLC 13 January 2025 Issued: 13 January 2025, London UK GSK enters agreement to acquire IDRx, Inc. · Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	16	1.19581464873	1338	1373.5	1289	6980557	1331.31648507	DE
4	34.5	2.61462675256	1319.5	1373.5	1289	5470596	1341.90280246	DE
12	-86	-5.97222222222	1440	1462	1282.5	8051701	1353.1404397	DE
26	-177.5	-11.5899444989	1531.5	1678	1282.5	7582929	1455.57570331	DE
52	-208.8	-13.3606347581	1562.8	1820	1282.5	7788162	1550.69045785	DE
156	-302.8	-18.2761950748	1656.8	1824.4	1282.5	8568186	1521.05652607	DE
260	-491.8	-26.6442734858	1845.8	1857	1190.8	8757593	1502.11239013	DE

GSK - Frequently Asked Questions (FAQ)

What is the current Gsk share price?

The current share price of Gsk is 1.354,00p

How many Gsk shares are in issue?

Gsk has 4.145.132.579 shares in issue

What is the market cap of Gsk?

The market capitalisation of Gsk is GBP 56,33B

What is the 1 year trading range for Gsk share price?

Gsk has traded in the range of 1.282,50p to 1.820,00p during the past year

What is the PE ratio of Gsk?

The price to earnings ratio of Gsk is 11,38

What is the cash to sales ratio of Gsk?

The cash to sales ratio of Gsk is 1,85

What is the reporting currency for Gsk?

Gsk reports financial results in GBP

What is the latest annual turnover for Gsk?

The latest annual turnover of Gsk is GBP 30,33B

What is the latest annual profit for Gsk?

The latest annual profit of Gsk is GBP 4,93B

What is the registered address of Gsk?

The registered address for Gsk is 79 NEW OXFORD STREET, LONDON, WC1A 1DG

What is the Gsk website address?

The website address for Gsk is www.gsk.com

Which industry sector does Gsk operate in?

Gsk operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
WSLWorldsec Ld	2,00p (60,00%)	105,37k
BLUBlue Star Capital Plc	12,00p (45,45%)	1,54M
NTQEnteq Technologies Plc	1,40p (40,00%)	19,81M
BANKFiinu Plc	10,25p (36,67%)	12,95M
TIRTiger Royalties And Investments Plc	0,16p (28,00%)	139,07M
PODPPod Point Group Holdings Plc	10,88p (-35,20%)	6,83M
PALMPanther Metals Plc	53,50p (-35,15%)	226,06k
NOGNostrum Oil & Gas Plc	2,51p (-23,82%)	117,6k
ADMEAdm Energy Plc	0,175p (-22,22%)	1,19M
PRDPredator Oil & Gas Holdings Plc	5,85p (-20,95%)	5,72M
NTVONativo Resources Plc	0,0021p (10,53%)	844,9M
TRPTower Resources Plc	0,0305p (-1,61%)	507,22M
PREMPremier African Minerals Limited	0,027p (-3,57%)	504,81M
SYMESupply@me Capital Plc	0,003p (-13,04%)	461,39M
ORCPOracle Power Plc	0,016p (-5,88%)	308,68M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Gsk Plc (GSK)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Gsk Plc

GSK Neueste Nachrichten

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

GSK PLC Jemperli expanded approval in the EU

GSK PLC Director/PDMR Shareholding

GSK PLC Director/PDMR Shareholding

GSK PLC Director/PDMR Shareholding

GSK PLC Director/PDMR Shareholding

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

GSK PLC GSK enters agreement to acquire IDRx, Inc.

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

GSK PLC Jemperli expanded approval in the EU

GSK PLC Director/PDMR Shareholding

GSK PLC Director/PDMR Shareholding

GSK PLC Director/PDMR Shareholding

GSK PLC Director/PDMR Shareholding

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

GSK PLC GSK enters agreement to acquire IDRx, Inc.

GSK - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Gsk Plc (GSK) Börsenkurse

Gsk Plc (GSK)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Gsk Plc

GSK Neueste Nachrichten

GSK - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen